AK-002 reduces GI eosinophils and symptoms in eosinophilic gastritis/duodenitis: phase I results Dec. 14, 2020
First phase III induction study with upadacitinib in ulcerative colitis meets primary endpoint Dec. 10, 2020
A-3907 targets bile acid transport in the intestine and kidney for treating NASH, fibrosis Dec. 2, 2020
RSS